Background-Phenotypic heterogeneity in autism has long been conjectured to be a major hindrance to the discovery of genetic risk factors, leading to numerous attempts to stratify children based on phenotype to increase power of discovery studies. This approach, however, is based on the hypothesis that phenotypic heterogeneity closely maps to genetic variation, which has not been tested. Our study examines the impact of sub-phenotyping of a well-characterized ASD sample on genetic homogeneity and the ability to discover common genetic variants conferring liability to ASD.
Introduction
Beyond its core diagnostic features, the presentation of autism spectrum disorder (ASD) often varies widely. Indeed many clinicians and researchers have remarked on its phenotypic heterogeneity and speculated that this heterogeneity is related to genetic variation (1) . These observations have led to the conjecture that a means of discovering novel genetic variation underlying liability for ASD is to amass a large sample and subset the sample on phenotypic dimensions (2, 3, 4) . The success of this approach relies on a relatively simple relationship between genetic and phenotypic variation. On the other hand, if the relationship were quite complex, so that myriad combinations of genetic variants could lead to similar phenotypic presentation, then this approach to discovery would be unlikely to be more successful than simply analyzing the total, albeit heterogeneous sample.
Such phenotypic sub-setting has successfully led to the identification of genetic variants in neurodevelopmental disorders. The severe developmental regression and stereotypical hand movements that typify Rett syndrome led to the identification of causal mutations in MECP2 (5) and FOXG1 (6) . Conversely, identical 3Mb deletions at the 22q11.2 locus lead to extensive phenotypic heterogeneity across a range of neuropsychiatric disorders (7) .
The results of several linkage studies in autism support the conjecture that stratifying children based on their phenotype yields genetically more homogeneous subgroups. Notably, for several studies the signal from linkage analysis increased substantially when the phenotype was narrowly defined, either using endophenotypes (8, 9, 10, 11) or dimensions stemming from factor analyses (12, 13, 14) . Nonetheless the limited congruence of results from larger samples (15, 16) and from the smaller samples suggests that sub-phenotyping has limited impact on reducing genetic heterogeneity.
In contrast to linkage studies of psychiatric disorders, replicable association findings for common genetic variants are now becoming commonplace. This is especially true for genetic studies of schizophrenia, presumably due in large part to the tens of thousands of samples amassed for study (17, 18, 19) . Indeed the number of discoveries and their replication are tightly correlated with sample size and comports with statistical theory of power for factors of small effect -as indeed all common variants affecting liability for schizophrenia appear to be. Aside from sample size, which lags for ASD, the genetics of ASD and schizophrenia have strong parallels. Liability for both appears to trace to common and rare variants, with the balance of liability -at the population level -tilted toward common variants (20, 21) .
For ASD there is now sound evidence that common variants, en masse, exert a substantial effect on ASD liability. Heritability of autism attributable to common variants is estimated to be 40-60% (22) and the variance of the phenotype explained by allele scores derived from GWAS results has been shown to be significant (23) . Thus, common variants play a major role in the pathophysiology of autism. Yet identifying even a small portion of those variants will be a major challenge for the next few years. Two paths for progress in this venture seem apparent: (1) use phenotypes to define clinical subgroups and thereby identify genetic variants accounting for more of the risk in the subgroup; or (2) genotype more affected and unaffected subjects or trios to increase sample size. While the results of schizophrenia studies suggest the second option is a successful path, the impact of reducing phenotypic heterogeneity on the ability to detect associated common variants remains to be determined.
A number of studies have attempted to identify informative clinical sub-phenotypes to reduce genetic heterogeneity and results from several studies suggest that certain clinical variables do improve statistical power of genetic analyses. Of these phenotypes, overall severity (4), Insistence on Sameness (IS) scores (24, 3) , and IQ (10, 25) have been proposed as defining clinical subgroups. Moreover, a recent study has built on the results of factor analyzes of autistic symptoms. Indeed most factor studies suggest that the structure of ASD phenotype is best conceptualized as a dyad of symptoms with distinct social communication and repetitive behavior dimensions (26, 27, 28) . Georgiades et al. (2) , using a mixture model, find distinct profiles of relative severity of social-communicative impairment and repetitive behaviors. Finally, while not beyond reasonable doubt (29, 30) , some studies suggest that DSM-IV categorical diagnosis could relate to more specific genetic liability (23, 31) .
While all of the aforementioned studies contain promising results, it is difficult to judge whether using more homogeneous presentations of ASD, as these studies do, truly garner more power or not. Indeed, although this approach is relatively common across the fields within psychiatric genetics, insofar as we are aware there has been no rigorous analysis of whether these approaches generate greater genetic homogeneity and greater power to detect risk loci. Here we take a first step in that direction. We examine how phenotypic subgrouping impacts genetic heterogeneity and the ability to discover common genetics variants affecting risk for ASD. To do so we use the genome-wide genotypic data from the SSC (32) the largest cohort of autism simplex families amassed to date. Phenotypic subgroups are defined on the basis of ASD diagnostic category, IQ, ASD severity, insistence on sameness, and symptom profiles. We then conduct a family-based association study, as well as estimating heritability and evaluating allele scores for each phenotypic subgroup. The results from this study suggest that, in ASD, greater phenotypic homogeneity has only a modest impact on genetic homogeneity and in only a few instances does it appear likely to be a productive path for discovering genetic risk variants.
Method Genotyping
Individuals from 2576 SSC families were genotyped for a million or more single nucleotide polymorphisms (SNPs) on one of three array versions -Illumina 1Mv1 (330 families), Illumina 1Mv3 Duo (1185 families), or Illumina HumanOmni2.5M (1061 families) -at the Yale Center for Genomic Analysis. Members of each family were analyzed on the same array version.
All individuals had call rates > 96.9% and thus all individuals were retained for analysis. Call rates for SNPs were determined for the 3,045,301 genotyped SNPs on the autosomes and chromosome X, in subsets of SNPs based on which platform produced the genotypes (Table S1 ). A total of 47,582 SNPs had a non-call rate > 2.5% and were subsequently removed from the analysis. Data were checked for reported sex, familial relationships and duplicates.
Phenotypes
Phenotypes were selected based on the previous research aimed at defining informative subgroups. Eleven groups ( Table 1) were defined based on diagnosis, IQ, age at first words, ASD severity, insistence sameness, and symptom profiles. Regression and epilepsy were considered for analysis (33, 34) , but were not included because they were relatively uncommon in the SSC cohort.
The first subgroup of the full data was formed by considering only probands with a categorical diagnosis of "autism" based on ADI-R and ADOS (N = 2,088). The second subgroup (N=1,851) included subjects with relatively high verbal IQ (vIQ>61, see supplemental methods). Three more groups targeted inclusion of the most severely impaired children, based on high severity score on i) the total ADOS calibrated severity score (35) , ii) the Social Affect (SA) calibrated severity score iii) the Restricted and Repetitive Behavior (RRB) calibrated severity score (36) . High severity was defined as a score of 8 or more for each subgroup.
The distribution of the insistence on sameness (IS) score (24, see supplemental methods) was quasi-continuous and relatively symmetric. Three subscores (difficulty with change, sensitivity to noise and circumscribed interests) were used to define three distinct subgroups, whereas the full IS score was used for quantitative trait analysis. A second quantitative trait analysis was performed with age at first words treated as a continuous variable.
Lastly, two subgroups emphasized repetitive behaviors, a common feature of subjects with ASD. The first subgroup included all individuals who had a calibrated ADOS RRB score equal to or superior to SA calibrated ADOS score. A second subgroup was restricted to individuals whose RRB calibrated ADOS score exceeded SA calibrated ADOS score by ≥2.
Genetic association analysis
For family-based association analysis we analyzed only trios from the family (mother, father and proband diagnosed with ASD). Association analyses were performed using an in-house 
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Author Manuscript program (37) that implements the conditional logistic regression form of family-based association and by FBAT (38) for analysis of quantitative traits. In all, 20 genome-wide association analyses were performed. Among these 18 included families of all ancestry groups: analysis of the whole sample; 10 subgroups (Table 1) ; two quantitative trait locus (QTL) analysis of insistence on sameness and age at first words; and parent-of-origin analyses for the entire sample, those subjects with strict autism diagnosis and subjects with higher IQ; and one was based on the European ancestry subset of the full data. A complete listing of the 20 analyses can be found in Table 2 . Note that results from SNPs showing strong association, yet with minor allele frequency MAF < 2.5% in parents and overtransmission of the common allele, were not displayed because they most likely represent false positive results.
Heritability estimates
Heritability was estimated in each subgroup as described elsewhere (22) . In brief it was estimated from comparing ASD subjects with 1,663 individuals from HealthABC (39) using the GCTA software (40) . The largest ASD sample analyzed comprised of subjects of European Ancestry (N=1633). All other subgroups were subsets of the European sample. To allow direct comparisons we used the same prevalence for ASD (0.01) for each subgroup.
Allele scores
We built on association results to compute a polygenic allele score and estimate the predictive value of this score for case control status, using the method developed by Purcell et al (41) . Allele scores were defined based on the GWA signals from the association analysis in the full sample (N = 2,576 families). All SNPs associated with a p-value<0.001 were included in the score computation. Of note, the p-value threshold was lower than in the previous analyses to limit the number of predictors (42) . For each autosomal SNP, the SNPspecific component of the score was calculated as the dosage of the risk allele multiplied by the corresponding log of the odds ratio. The allele-score approach requires controls as well as cases. Thus in each family a pseudo-control was generated by comparing the genotype of the parents to that of the proband and assigning the un-transmitted allele of each parent as the alleles for the pseudo-control's genotype. After generating a pseudo-control for each SNP and family, the individual-specific score was calculated by summing over the SNPspecific component values for each individual from the whole sample, using PLINK version 1.07 (41) . Last, a logistic regression estimated the predictive value of the allele score for the case/control status.
Results

Association analyses
The association results are split into four categories: genome-wide significant (p <5 × 10 -8 ); suggestive (p between 5 × 10 -7 and > 5 × 10 -8 ); unreliable (p < 5 × 10 -7 , but with all the hallmarks of genotyping error (43), including MAF < 0.05 and over-transmission of the major allele); and non-significant (p > 5 × 10 -7 ). Only the genome-wide significant and suggestive findings will be reported in this manuscript. P-values are uncorrected for the 20 association tests performed. 
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No genome-wide significant SNPs were identified in a GWAS analysis of the complete dataset, or in any of the 18 phenotypic subsets of the data (Table 2 ). However, seven SNPs, meeting the threshold for suggestive association (p <5 × 10 -7 ) look promising (Table 3) . Among these, 6 SNPs are either located in, or have been shown to affect the expression of four genes involved in DNA integrity maintenance: CTU2, CUEDC2, ZNF365, TOPBP1 (44, 45, 46, 47, 48) . Moreover, one of these SNPs (rs1409313) was shown to regulate cerebellum expression of C10orf26 (49), a gene associated with schizophrenia (50) .
Analysis of the impact of sub-phenotyping on association results
Over all SNPs an obvious and anticipated impact of phenotypic subgrouping is to reduce the size of association statistic (one sided z decreases and p-values increase). In general, if subsamples are merely a random subsample of the larger sample, test statistics diminish in a very predictable fashion, specifically as the square root of the sample size for each subsample. In this study, association statistics (one-sided-z) on average diminish as a function of the square root of the sample size (Fig. 1a) . The pattern itself is unremarkable because statistical theory shows power has this functional relationship, but what is remarkable is how closely the points adhere to the linear relationship.
Another way to view the influence of phenotypic subgrouping on association between SNP and case status is to examine how the p-value changes from the full sample to that for the subgroup. To examine this effect we conducted secondary analyses and selected a subset of 21,351 SNPs based on the following association results from the whole sample: p-value < 0.01 and OR > 1 if an allele with MAF < 0.025. To compare all subgroups, p-values in each subgroup were transformed into absolute values of the associated Z-scores. The difference between the one sided z score in the subgroup and the one sided z score in the full sample, corresponding to the shift toward association in the subgroup, was standardized ( Fig. 1B) .
We did not observe a significant shift toward association (i.e. a standardized difference >4.58, corresponding to a p-value = 0.05/21351) for any SNP in any subgroup. However, the results of these secondary analyses were suggestive for 11 SNPs. Indeed, these SNPs were associated with case status with a p value < 2× 10 -6 (i.e. significant when correcting for 21351 markers) in at least one of the subgroups analyses and standardized differences among the largest (>2) ( Table 4 ). Among those, 6 SNPs were located in 4 genes (FBXW7, ZNF365, CTU2, PTCHD1), and one (rs3856064 on chromosome 1) was reported (www.scandb.org (49) ) to regulate the expression of STX6 gene in parietal cortex. FBXW7 is involved in genome stability, and more specifically checkpoint signaling, through the regulation of cyclin E (51) . Although the exact function of PTCHD1 is not known, it is thought to be involved in Hedgehog signaling which regulates the formation of the neural tube and brain (52) .
Impact of sub-phenotyping on the genetic architecture of ASD
After examining the impact of sub-phenotyping on association statistics for each SNP, we evaluated its impact on genetic features of the sample as measured through a large number of SNPs, assessed jointly. In particular we investigated how heritability and allele scores changed across subgroups.
Heritability of this sample was previously evaluated by Klei et al. (22) . In that study heritability was estimated from samples of European ancestry genotyped on the Illumina 1Mv1 or the Illumina 1Mv3 array. To be consistent with that study, we used the same approach and sample, after removing a small set of families according to the updated SSC participants list (these families being excluded mostly because of withdrawal of consent or additional cases in the simplex family, thereby altering its simplex status). For the ASD sample the estimated heritability was 0.401 (Fig 2, Table S2 ) and subgroups of this sample were not statistically different from the whole sample or other subsets. Estimated heritability, however, showed a trend toward a higher heritability estimate in the three subgroups defined by an excess of repetitive behaviors.
A total of 2438 SNPs with a MAF > 0.025 showed an association p-value < 0.001 in the full ASD data. The allele score based on this set of SNPs explained around 0.454 the variance in case control status (pseudoR 2 ) based on the whole sample and performed similarly for each subgroup (Fig. 3) , indicating that the predictive value of the score does not differ materially amongst these samples. One can take a different approach in which one generates an allele score for each of the samples in Figure 3 , yet such an approach yields results indistinguishable from those in Figure 3 (data not shown).
Discussion
A longstanding conjecture regarding the genetics of ASD is that ASD's great phenotypic heterogeneity is a key hindrance to the discovery of genetic factors conferring liability. Consequently, disentangling this heterogeneity has been deemed an essential step toward identification of genetic variants affecting risk (2, 13, 4) . The results of this study, however, suggest that this approach cannot ensure success. To the contrary the results suggest that observable clinical variation phenotypic variability does not map closely onto common genetic variation.
The paucity of SNPs that emerge with certain sub-phenotypes suggests that subgrouping based on phenotype does not substantially increase power to detect associated common variants (Fig. 1A) . One could argue that this is because sub-phenotyping loses power by reducing the size of the sample and that recruiting larger samples with homogeneous phenotype would lead to the identification of some associated SNPs. However, test statistics closely follow the expected linear relationship with square root of sample size. (Fig. 1A) , suggesting that sub-phenotypes are not highly informative for genetic discovery. (Indeed, if sub-phenotypes were highly informative for genetic discovery we would expect some noteworthy deviation from the linear fit observed in Figure 1 ). Alleles scores, based on a small subset of SNPs, predict case status in the full sample and in subsamples based on various phenotypes (e.g., meeting ASD diagnostic criteria and manifesting repetitive behaviors) equally well. The similarity of the proportion of variance explained among subgroups suggests that subgrouping does not contribute much to our understanding of the genetics of risk for ASD in its various clinical forms. Taken together with the similarity of heritability estimates across subsamples this strongly suggests that subgrouping based on clinical phenotypes does little to modify the genetic architecture of autism risk in each subgroup and does not substantially increase genetic homogeneity. Consistent with these results, sub-phenotyping does not significantly shift one sided z scores toward higher values for any SNP. Remarkably, heritability estimates in the higher IQ group and the full sample show very little difference, even ignoring sampling error suggesting that the architecture of autism risk is similar in high IQ and low IQ populations. Intriguingly, this result appears at odds with the observation of a significant enrichment for de novo loss of function mutations in individuals with low IQ (53) . We can not exclude that the relatively small size of the sample of people with low IQ, due to the large fraction of individuals with high IQ in the SSC, could obscur the difference in heritability. However, the results are also consistent with common variants making similar contribution to the ASD phenotype for both groups, while de novo mutations, in general, have a modest impact on risk for ASD and a greater impact on IQ. This interpretation is consistent with the conjecture of Samocha et al. (53) . In this regard, when we excluded individuals with a clinically relevant CNV, which are likely to have a substantial impact on IQ (54), it did not substantially change association results (unpublished data).
These results, however, cannot be taken to mean that clinical phenotypes have no impact on power for discovering genetic associations and no underlying genetic basis. At some level they must, but the mapping of genotype and phenotype appears to be almost as complex as that between genotype and ASD itself. Still, examining the results of each subgroup separately raises the possibility that probands with high repetitive behaviors are a slightly more genetically homogeneous group and one worth further exploration. It is noteworthy that several lines of evidence support the existence of a different genetic etiology for RRB and SA symptoms (55, 56) . Moreover, while some studies have suggested that the genetic architecture of autism risk slightly differs between sex (57, 58, 59) , RRB have been found to be the main symptoms to be differently distributed between sex (60, 27, 59) . The SNP which was found to be significantly shifted toward association in the high RRB subgroup, rs11641365, is located in CTU2.
Although no locus reached statistical significance after correcting for genome wide multiple testing in primary analyses, some of the genes that emerge from primary and secondary association analyses (CTU2, CUEDC2, ZNF365, TOPBP1, FBXW7; Tables 3 and 4 ) raise the possibility of a role for maintenance of genomic integrity in the pathophysiology of autism, a role highlighted in recent sequencing analyses of the 15q13.3 region (61). In addition FBXW7, which targets mTOR for ubiquitination and degradation and cooperates with PTEN (62), plays a key role in neural stem cell differentiation (63) , and is required for cerebellar development (64) . ZNF365 isoform D regulates the expression of DISC-1, a gene implicated in schizophrenia risk (65, 66) . STX6 is a SNARE component (67) and thus may play a role in synaptic transmission. Finally PTCHD1 has been previously implicated in autism and intellectual disability (68, 52, 69, 70, 71) . Interestingly the SNP rs5971115 was found to be substantially shifted toward association in the group with strict autistic disorder, which is characterized by a low IQ. However, it is important to underscore that all these association results are exploratory, none are statistically significant, and only additional independent data can determine what role, if any, they play in liability.
While we acknowledge that these results are based on a limited selection of phenotypesand there still could be phenotypes, including biomarkers, which could be informative -they are in line with the body of work that has led to the single ASD category in DSM-5 classification (29 . They support ASD categorical diagnosis as a valid entity for the search of common variants increasing risk, which is consistent with high heritability estimates for ASD found in most studies (73, 22, 74) . There are other limitations to our study, including its sample size, which could always be larger; perhaps the strict simplex nature of the families, which could limit heritable variation (22) ; somewhat reduced variability of phenotypes like IQ and ASD severity; and use of ASD/ID related behavioral phenotypes as opposed to medical and psychiatric comorbidity. On the other hand, taking the results presented here together with the emerging picture of autism risk architecture regarding for common variants, they suggest that phenotype is the result of the complex combination of a large number of modest allelic effects on each trait. If, as some authors have proposed, we can assume that there is no common variant of substantial effect on the risk of ASD (odds ratio> 1.2), but a great number of common variations with a more modest impact (75) , the identification of common risk variants is hindered mainly by sample size and only marginally by clinical heterogeneity even in samples carefully phenotyped to confirm an ASD diagnosis. Thus the results of this study advocate for recruitment of larger cohorts of ASD subjects to identify common variation affecting risk for ASD. Indeed, while GWAS studies in ASD are large relative to earlier candidate gene studies, their sample sizes are still small relative to the majority of the studies in other complex diseases. 
